Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:566-570
Published online before print December 23, 2004, doi: 10.1161/01.ATV.0000154135.21689.47
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/3/566    most recent
01.ATV.0000154135.21689.47v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asp, L.
Right arrow Articles by Olofsson, S.-O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asp, L.
Right arrow Articles by Olofsson, S.-O.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:566.)
© 2005 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Role of ADP Ribosylation Factor 1 in the Assembly and Secretion of ApoB-100–Containing Lipoproteins

Lennart Asp; Björn Magnusson; Mikael Rutberg; Lu Li; Jan Borén; Sven-Olof Olofsson

From the Department of Medical Biochemistry, Wallenberg Laboratory for Cardiovascular Research, Göteborg University, Göteborg, Sweden.

Correspondence to Sven-Olof Olofsson, The Wallenberg Laboratory, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. E-mail Sven-Olof.Olofsson{at}medkem.gu.se

Objective— We investigated the role of ADP ribosylation factor 1 (ARF1) in the assembly of very-low-density lipoproteins (VLDLs).

Methods and Results— The dominant-negative ARF1 mutant, T31N, decreased the assembly of apoB-100 VLDL 1 (Svedberg floatation units [Sf] 60 to 400) by 80%. The decrease coincided with loss of coatamer I (COPI) from the Golgi apparatus and inhibition of anterograde transport, as demonstrated by time-lapse studies of the vesicular stomatitis virus G protein. The VLDL 1 assembly was also completely inhibited at 15°C. Thus, the antegrade transport is essential for the assembly of VLDL 1. Intracellular localization of N-acetylgalactosaminyl transferase 2 indicated that the Golgi apparatus was at least partly intact when the VLDL assembly was inhibited. Transient transfection with phospholipase D 1 increased the assembly of VLDL 1 and VLDL 2 (Sf 20 to 60). Overexpression of ARF1 in stably transfected McA-RH7777 cells increased the secretion of VLDL 2 but not of VLDL 1, which was dependent on the availability of oleic acid. Secretion of VLDL 1 increased with increasing amounts of oleic acid, and VLDL 2 secretion decreased simultaneously.

Conclusions— Overexpression of ARF1 increased the assembly of VLDL 2 but not of VLDL 1, whose production was dependent on both anterograde transport and the availability of fatty acids.

The assembly of VLDL depends on the ARF1-driven anterograde transport. Overexpression of ARF1 increases the secretion of VLDL 2 but not of VLDL 1, which is highly dependent on of fatty acids. The secretion of both VLDL 1 and VLDL 2 are increased by phospholipase D 1.


Key Words: ADP ribosylation factor 1 • apolipoprotein B • coatamer 1 • intracellular transport • very-low-density lipoproteins




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Adiels, S.-O. Olofsson, M.-R. Taskinen, and J. Boren
Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1225 - 1236.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Lambert, A.-L. Jarnoux, T. Pineau, O. Pape, M. Chetiveaux, C. Laboisse, M. Krempf, and P. Costet
Fasting Induces Hyperlipidemia in Mice Overexpressing Proprotein Convertase Subtilisin Kexin Type 9: Lack of Modulation of Very-Low-Density Lipoprotein Hepatic Output by the Low-Density Lipoprotein Receptor
Endocrinology, October 1, 2006; 147(10): 4985 - 4995.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Magnusson, L. Asp, P. Bostrom, M. Ruiz, P. Stillemark-Billton, D. Linden, J. Boren, and S.-O. Olofsson
Adipocyte Differentiation-Related Protein Promotes Fatty Acid Storage in Cytosolic Triglycerides and Inhibits Secretion of Very Low-Density Lipoproteins
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1566 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S.-O. Olofsson
ApoA-V: The Regulation of a Regulator of Plasma Triglycerides
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1097 - 1099.
[Full Text] [PDF]